secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001628280-23-031771
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics furnishes September 2023 corporate presentation
--------------------------------------------------------------------

- Presentation highlights chromatin regulatory platform for precision oncology therapies.
- No financial results, clinical data, or guidance changes disclosed in the exhibit.
- Materials intended for investor meetings; no material new operational update provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828023031771/0001628280-23-031771-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828023031771/fhtx-20230908.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-031771

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer